Article
Gilteritinib-induced severe immune-related enteritis: a possible case report
2022-08-18
Abstract excerpt
This case report describes a 49-year-old woman who diagnosed with acute myeloid leukaemia (AML) harbouring FMS-like tyrosine kinase 3 (FLT3) mutations developed a severe suspected immune-related enteritis during treatment with gilteritinib for maintenance therapy following allo-hematopoietic stem cell transplantation (HSCT). According to the results of Naranjo probability scale, gilteritinib was defined as a ‘poss...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee4afe71-6ca6-50c3-b85f-c956d579d475
- DOI
- 10.22541/au.166082764.45680542/v1
